anticol3a1 Search Results


col3a1  (Atlas Antibodies)
90
Atlas Antibodies col3a1
Confirmation and validation of ECM genes . a Confirmation of ECM genes was done by real-time PCR analysis of the samples used in the RNA-seq analysis. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001). b Validation of ECM genes was done by real-time PCR using new patient-derived individual BRCA1 mut and non-carrier organoids treated with E2+P4 and E2+P4+TPA. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001. c IHC staining of ECM proteins MMP10, COL1A1, <t>COL3A1,</t> and FN1 were performed in non-carrier and BRCA1 mut organoids. Scale bar, 100 μm
Col3a1, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/col3a1/product/Atlas Antibodies
Average 90 stars, based on 1 article reviews
col3a1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
goat anti-col3a1 antibody  (Biodesign International Inc)
90
Biodesign International Inc goat anti-col3a1 antibody
Confirmation and validation of ECM genes . a Confirmation of ECM genes was done by real-time PCR analysis of the samples used in the RNA-seq analysis. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001). b Validation of ECM genes was done by real-time PCR using new patient-derived individual BRCA1 mut and non-carrier organoids treated with E2+P4 and E2+P4+TPA. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001. c IHC staining of ECM proteins MMP10, COL1A1, <t>COL3A1,</t> and FN1 were performed in non-carrier and BRCA1 mut organoids. Scale bar, 100 μm
Goat Anti Col3a1 Antibody, supplied by Biodesign International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti-col3a1 antibody/product/Biodesign International Inc
Average 90 stars, based on 1 article reviews
goat anti-col3a1 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti col3a1  (Cusabio)
91
Cusabio anti col3a1
Confirmation and validation of ECM genes . a Confirmation of ECM genes was done by real-time PCR analysis of the samples used in the RNA-seq analysis. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001). b Validation of ECM genes was done by real-time PCR using new patient-derived individual BRCA1 mut and non-carrier organoids treated with E2+P4 and E2+P4+TPA. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001. c IHC staining of ECM proteins MMP10, COL1A1, <t>COL3A1,</t> and FN1 were performed in non-carrier and BRCA1 mut organoids. Scale bar, 100 μm
Anti Col3a1, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti col3a1/product/Cusabio
Average 91 stars, based on 1 article reviews
anti col3a1 - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier
anti-col3a1 (p104) (bs1531)  (Bioworld Antibodies)
90
Bioworld Antibodies anti-col3a1 (p104) (bs1531)
Confirmation and validation of ECM genes . a Confirmation of ECM genes was done by real-time PCR analysis of the samples used in the RNA-seq analysis. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001). b Validation of ECM genes was done by real-time PCR using new patient-derived individual BRCA1 mut and non-carrier organoids treated with E2+P4 and E2+P4+TPA. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001. c IHC staining of ECM proteins MMP10, COL1A1, <t>COL3A1,</t> and FN1 were performed in non-carrier and BRCA1 mut organoids. Scale bar, 100 μm
Anti Col3a1 (P104) (Bs1531), supplied by Bioworld Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-col3a1 (p104) (bs1531)/product/Bioworld Antibodies
Average 90 stars, based on 1 article reviews
anti-col3a1 (p104) (bs1531) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-col3a1  (Rockland Immunochemicals)
90
Rockland Immunochemicals anti-col3a1
Confirmation and validation of ECM genes . a Confirmation of ECM genes was done by real-time PCR analysis of the samples used in the RNA-seq analysis. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001). b Validation of ECM genes was done by real-time PCR using new patient-derived individual BRCA1 mut and non-carrier organoids treated with E2+P4 and E2+P4+TPA. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001. c IHC staining of ECM proteins MMP10, COL1A1, <t>COL3A1,</t> and FN1 were performed in non-carrier and BRCA1 mut organoids. Scale bar, 100 μm
Anti Col3a1, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-col3a1/product/Rockland Immunochemicals
Average 90 stars, based on 1 article reviews
anti-col3a1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Confirmation and validation of ECM genes . a Confirmation of ECM genes was done by real-time PCR analysis of the samples used in the RNA-seq analysis. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001). b Validation of ECM genes was done by real-time PCR using new patient-derived individual BRCA1 mut and non-carrier organoids treated with E2+P4 and E2+P4+TPA. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001. c IHC staining of ECM proteins MMP10, COL1A1, COL3A1, and FN1 were performed in non-carrier and BRCA1 mut organoids. Scale bar, 100 μm

Journal: Breast Cancer Research : BCR

Article Title: BRCA1 mutation influences progesterone response in human benign mammary organoids

doi: 10.1186/s13058-019-1214-0

Figure Lengend Snippet: Confirmation and validation of ECM genes . a Confirmation of ECM genes was done by real-time PCR analysis of the samples used in the RNA-seq analysis. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001). b Validation of ECM genes was done by real-time PCR using new patient-derived individual BRCA1 mut and non-carrier organoids treated with E2+P4 and E2+P4+TPA. The data are fold changes of hormone treatment (dotted red line) and represent the mean ± SEM from three technical replicates (* p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001. c IHC staining of ECM proteins MMP10, COL1A1, COL3A1, and FN1 were performed in non-carrier and BRCA1 mut organoids. Scale bar, 100 μm

Article Snippet: The primary antibodies used were ER (1:200, Santa Cruz SC71064), PR (1:200, DAKO, M3568), pan cytokeratin (panCK; 1:200, Abcam, ab7753), Cytokeratin 18 (CK18; 1:200, Abcam, 93741), vimentin (Vim; 1:200, Abcam, 92547), α smooth muscle actin (αSMA; 1:200, Novus Biologicals, 600531), Cytokeratin 5/6 (CK5/6; 1:200, Agilent Technologies, M723729-2), COL3A1 (Atlas antibodies, 1:200, HPA007583), COL1A1 (LS Bio, 1:400, LS-C343921), MMP10 (LS Bio, 1:400, LS-C118518), MMP1(LS Bio, 1:400, LS-B8645), Ki67 (Dako, 1:200, GA62661-2), E-cadherin (BD Biosciences, 1:200, 610181), ITGB4 (LS Bio, 1:200, LS-B3778), and ALDH1A1 isoform (LSBio, 1:400, LS-B10149).

Techniques: Biomarker Discovery, Real-time Polymerase Chain Reaction, RNA Sequencing, Derivative Assay, Immunohistochemistry